In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Tensor Biosciences

Tensor Biosciences Inc.

Tensor Biosciences has a system that can monitor the neuronal network activity in a slice of the "living brain: tissue for several weeks. The system is useful for early and late stage central nervous system drug discovery. A first-generation system is on the market, and a second generation, higher-throughput system is expected out in 2003. The technology was developed at Matsushita Electric Industrial Co. for non-medical, computer applications. MEI gave it to Tensor for medical applications, and a senior project manager at MEI is a co-founder of Tensor.

BioPharmaceutical Business Strategies
See All
UsernamePublicRestriction

Register